| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/15/1991 | US4985548 4-demethoxy-4-amino-anthracyclines |
| 01/15/1991 | US4985447 Certain benzoquinones, naphthoquinones and derivatives thereof which exhibit thromboxane A2 synthetase inhibition or receptor antagonism and the like |
| 01/15/1991 | US4985441 Anti-tumor agents |
| 01/15/1991 | US4985436 Composition of matter for inhibiting leukemias and sarcomas |
| 01/15/1991 | US4985416 Platinum complexes of azodiazonium dyes as anti-tumor agents |
| 01/15/1991 | US4985405 Therapeutic product based on organic silicon derivatives |
| 01/15/1991 | CA2062975A1 Antagonists of gm-csf derived from the carboxyl terminus |
| 01/10/1991 | WO1991000295A1 Novel antibodies reactive with human carcinomas |
| 01/10/1991 | WO1991000289A2 Targeted liposomes and methods for liposome-protein coupling |
| 01/10/1991 | WO1991000285A1 Tri-aza macrocycles and processes for their preparation |
| 01/10/1991 | WO1991000271A1 Novel vitamin d analogues |
| 01/10/1991 | WO1991000111A1 Targetting agents |
| 01/10/1991 | WO1991000093A1 Bis-acyloxymethyl derivatives |
| 01/10/1991 | WO1990013643A3 Glycoprotein hormone receptor molecules |
| 01/09/1991 | EP0407122A1 Novel modified PF4 compositions and methods of use |
| 01/09/1991 | EP0406880A2 Method for stimulating macrophage activity against tumors and composition therefor |
| 01/09/1991 | EP0406749A1 DC-88A derivatives |
| 01/09/1991 | EP0406725A1 Cyclic tetrapeptide and process for preparing the same |
| 01/09/1991 | EP0406428A1 Peptide derivatives and their use |
| 01/09/1991 | EP0406408A1 Antivirals and methods for increasing the antiviral activity of azt |
| 01/09/1991 | EP0406259A1 Antibodies, process for producing them, clones for the production of the antibodies, and use of the antibodies for diagnosis and therapy of tumours. |
| 01/09/1991 | CN1048390A N-acyl derivatives of ll-e 33288 antitumor antibiotics |
| 01/09/1991 | CN1048327A Compositions useful as contraceptives in males |
| 01/08/1991 | US4983724 Oxidation, stereoselective reduction with hydride, hydroxy protecting groups |
| 01/08/1991 | US4983636 Composition and method of treating selected malignant conditions |
| 01/08/1991 | US4983606 Pharmaceutically-active phthalazine compounds |
| 01/08/1991 | US4983604 Inhibitors of nonenzymatic cross-linking |
| 01/08/1991 | US4983328 N-(4-(3-aminopropyl)aminobutyl)-2-(ω-guanidino-fatty-acid-amido(-2-substituted-ethanamide, salt thereof, and process for preparation thereof |
| 01/08/1991 | CA2020593A1 Method for stimulating macrophage activity against tumors and composition therefor |
| 01/08/1991 | CA1278791C Furfuryl derivatives of vinblastine-type bisindoles, pharmaceutical compositions containing them and process for preparing same |
| 01/08/1991 | CA1278790C Bis-indole derivatives, pharmaceutical compositions containing them andprocess for preparing same |
| 01/07/1991 | WO1991001004A1 Hybrid molecules |
| 01/07/1991 | CA2035868A1 Hybrid molecules |
| 01/06/1991 | CA2019086A1 Modified pf4 compositions and methods of use |
| 01/02/1991 | EP0405788A2 Di-tert-butyl(hydroxy)phenylthio substituted hydroxamic acid derivatives |
| 01/02/1991 | EP0405748A1 Phosphonoderivative of purine with antiviral activity |
| 01/02/1991 | EP0405617A2 Medicaments for the treatment of anxiety |
| 01/02/1991 | EP0405463A2 Supporting agents for anti-cancer therapy |
| 01/02/1991 | EP0405028A1 Thiochroman esters of phenols and terephthalates having retinoid-like activity |
| 01/02/1991 | EP0144396B1 Polyhydroxybenzoic acid derivatives |
| 01/02/1991 | CA1278518C Methods and compositions for the treatment of tumors by administering a platinum coordination compound and a calcium channel blocker compound of the dihydropyridine class |
| 01/02/1991 | CA1278516C Adriamycin-entrapping liposome preparation |
| 01/02/1991 | CA1278515C Pharmaceutical composition for combination therapy of hormone dependent cancers |
| 01/01/1991 | US4981953 Antitumor |
| 01/01/1991 | US4981869 Xanthates as antitumor agents |
| 01/01/1991 | US4981864 Method for inhibition of erythrocyte aggregation using anellated tricyclic compounds |
| 01/01/1991 | US4981856 Anti-tumor agents |
| 01/01/1991 | US4981842 Antitumor peptides |
| 12/28/1990 | WO1991000095A1 Compositions useful as contraceptives in males |
| 12/28/1990 | CA2059138A1 Compositions useful as contraceptives in males |
| 12/27/1990 | WO1990015884A1 Formation of triple helix complexes of double stranded dna using nucleoside oligomers |
| 12/27/1990 | WO1990015816A1 Suramin type compounds and angiostatic steroids to inhibit angiogenesis |
| 12/27/1990 | WO1990015626A1 Methods for technetium/rhenium labelling of proteins |
| 12/27/1990 | EP0404640A1 5,6,7,8-Tetrahydro-1-naphtalenol derivatives, process for their preparation and their use as antioxidants in cosmetic and pharmaceutical compositions |
| 12/27/1990 | EP0404605A2 Tri-aza macrocycles and processes for their production |
| 12/27/1990 | EP0404097A2 Bispecific and oligospecific, mono- and oligovalent receptors, production and applications thereof |
| 12/27/1990 | EP0404055A1 Ghilanten: antimetastatic principle from the south american leech, haementeria ghilianii |
| 12/27/1990 | EP0403963A2 Anthracycline derivatives, process for their preparation and their use as medicaments |
| 12/27/1990 | EP0362258A4 Liposome/doxorubicin composition and method |
| 12/27/1990 | EP0257084B1 Use of a dipeptide with cell growth regulating effect for the preparation of a medicament |
| 12/27/1990 | CA1278304C Taxol derivatives, their preparation and pharmaceutical compositions containing them |
| 12/26/1990 | CN1047973A Stable freeze dried polyhematoporphyrin ether/ester composition |
| 12/25/1990 | US4980509 Aromatic polycyclic derivatives, their process of preparation and their use in human and veterinary medicine and in cosmetics |
| 12/25/1990 | US4980457 Coupling of ricin and antibody |
| 12/25/1990 | US4980369 Acetylenes disubstituted with a phenyl group and a 2-substituted chromanyl or thiochromanyl group having retinoid-like activity |
| 12/25/1990 | US4980343 Aminooxodihydroisoindoloquinazoline carcinostatic agents |
| 12/25/1990 | US4980163 Lysostaphin and lanthionine containing bacteriocin |
| 12/25/1990 | US4980149 Reduction of the toxic effects caused by anthraquinone drugs |
| 12/23/1990 | WO1990015799A1 Indenoindole compounds ii |
| 12/23/1990 | CA2060897A1 Indenoindole compounds ii |
| 12/20/1990 | WO1990015625A1 RADIOIMMUNOTHERAPY USING α-PARTICLES EMISSION |
| 12/20/1990 | WO1990015599A1 Medicaments useful in cancer therapy and having antihistaminic properties |
| 12/20/1990 | CA2059127A1 Medicaments useful in cancer therapy and having antihistaminic properties |
| 12/20/1990 | CA2019315A1 Anthracycline derivatives, a process for the preparation thereof and the use thereof as a pharmaceutical |
| 12/19/1990 | EP0403318A1 Process for the preparation of an anti-tumor substance, 3-amino-1-(2-amino-1H-imidazolyl-4)-2-chloro-1-propanol and his salts in the threo-racemic-form, for use as a medicament |
| 12/19/1990 | EP0403225A2 Methods for technetium/rhenium labelling of proteins |
| 12/19/1990 | EP0402903A1 Production of pyrrolopyrimidines and intermediates therefor |
| 12/19/1990 | EP0402852A1 Irreversible bombesin antagonists |
| 12/19/1990 | EP0402637A2 Stable freeze dried polyhematoporphyrin ether/ester composition |
| 12/19/1990 | EP0402544A1 Nucleotide sequence encoding plant ribosome inactivating protein |
| 12/19/1990 | CN1047869A Acylated derivatives of etoposide |
| 12/19/1990 | CN1047803A Etoposide preparations |
| 12/19/1990 | CA2019156A1 Formation of triple helix complexes of double stranded dna using nucleoside oligomers |
| 12/18/1990 | US4978783 2,6-dimethoxyhydroquinone-3-mercaptopropionic acid, 2,6-dimethoxyhydroquinone-3-mercaptoacetic acid, and antitumor use thereof |
| 12/18/1990 | US4978745 Immunoreactive heterochain antibodies |
| 12/18/1990 | US4978683 Administering to humans having pancreatic, colic or gastric tumors whose growth is increased by bioactive polypeptides |
| 12/18/1990 | US4978332 Treatments employing vasoconstrictive substances in combination with cytotoxic agents for introduction into cellular lesion areas |
| 12/18/1990 | CA1277912C Radiosensitization by cobalt and fe (iii) complexes |
| 12/16/1990 | WO1990015819A1 Irreversible bombesin antagonists |
| 12/16/1990 | CA2034480A1 Irreversible bombesin antagonists |
| 12/13/1990 | WO1990014843A1 Drugs for tumour therapy in conjunction control with and regulation of the immune system and use of the individual substances for combined therapy |
| 12/13/1990 | CA2018959A1 Tetrahydro-5,6,7,8 naphtalenol-1 derivatives, process for their preparation and use as antioxidant in cosmetic compositions and pharmaceutical products containing same |
| 12/12/1990 | EP0402259A1 Anthracyclines, process for their preparation and medicaments containing them |
| 12/12/1990 | EP0402232A1 Pyridobenzoindole derivatives, their preparation and compositions containing them |
| 12/12/1990 | EP0401997A1 Process to prepare metastasis-inhibitory factor |
| 12/12/1990 | EP0401963A1 Phosphonopeptides with collagenase inhibiting activity |
| 12/12/1990 | EP0401929A2 Method of preparing N-oxotetrahydro- -carbolines |
| 12/12/1990 | EP0401896A1 Carboplatin composition |
| 12/12/1990 | EP0401800A2 Acylated derivatives of etoposide |
| 12/12/1990 | EP0401695A1 Etoposide preparation |